Calim Muhittin, Yesiltas Serdar, Gunay Mustafa, Sumer Ismail, Akdas Sedat
Bezmialem Vakif University Faculty of Medicine, Department of Anesthesiology and Reanimation, Istanbul, Turkey.
Medeni Med J. 2023 Sep 28;38(3):210-217. doi: 10.4274/MMJ.galenos.2023.99975.
Efficient pain management following arthroscopic shoulder surgery plays a crucial role in decreasing pain intensity, tramadol consumption, and related side effects. This study primarily aimed to examine the analgesic impact of intravenous (IV) ibuprofen and paracetamol on postoperative pain intensity. In addition, as secondary objectives, the study assesses tramadol consumption, determine the global satisfaction score (GSS), analyze hemodynamic parameters, and investigate tramadol-related side effects.
In this study, we enrolled sixty-four patients who were scheduled to undergo arthroscopic shoulder surgery and met the inclusion criteria of having American Society of Anesthesiologists scores between 1 and 3 and falling within the age range of 18 to 85 years. All participants were managed using IV patient-controlled analgesia. These patients were then randomly assigned in a double-blind manner to two groups: one receiving paracetamol (n=32), and the other receiving ibuprofen (n=32). Demographic information, visual analog scale (VAS) and GSS data, hemodynamics, tramadol consumption, and tramadol-related side effects were recorded.
There were no significant differences between the two groups regarding demographics, hemodynamics, GSS scores, and tramadol side effects (respiratory depression, pruritus, urinary retention, and nausea and vomiting). VAS scores of the two groups were similar at postoperative 1, 6, and 12 hours. However, group ibuprofen significantly reduced the VAS scores at the postoperative 24 hour (p=0.039). On the other hand, the two groups showed no significant differences in GSS scores. Compared with total tramadol consumption during the postoperative 24-hour period, ibuprofen significantly reduced tramadol consumption (p=0.003).
The findings of this study indicate a significant reduction in both pain intensity and tramadol consumption when IV ibuprofen was administered 24 hours following arthroscopic shoulder surgery, in comparison with the use of IV paracetamol.
肩关节镜手术后有效的疼痛管理在减轻疼痛强度、曲马多消耗量及相关副作用方面起着至关重要的作用。本研究主要旨在探讨静脉注射布洛芬和对乙酰氨基酚对术后疼痛强度的镇痛效果。此外,作为次要目标,本研究评估曲马多消耗量,确定总体满意度评分(GSS),分析血流动力学参数,并调查曲马多相关副作用。
在本研究中,我们纳入了64例计划接受肩关节镜手术且符合入选标准的患者,其美国麻醉医师协会评分为1至3分,年龄在18至85岁之间。所有参与者均采用静脉自控镇痛进行管理。然后将这些患者以双盲方式随机分为两组:一组接受对乙酰氨基酚(n = 32),另一组接受布洛芬(n = 32)。记录人口统计学信息、视觉模拟评分(VAS)和GSS数据、血流动力学、曲马多消耗量以及曲马多相关副作用。
两组在人口统计学、血流动力学、GSS评分和曲马多副作用(呼吸抑制、瘙痒、尿潴留以及恶心和呕吐)方面无显著差异。两组在术后1、6和12小时的VAS评分相似。然而,布洛芬组在术后24小时显著降低了VAS评分(p = 0.039)。另一方面,两组在GSS评分方面无显著差异。与术后24小时内曲马多的总消耗量相比,布洛芬显著降低了曲马多消耗量(p = 0.003)。
本研究结果表明,与静脉注射对乙酰氨基酚相比,肩关节镜手术后24小时静脉注射布洛芬可显著降低疼痛强度和曲马多消耗量。